Literature DB >> 29295872

Fibrotic Venous Remodeling and Nonmaturation of Arteriovenous Fistulas.

Laisel Martinez1, Juan C Duque2, Marwan Tabbara1, Angela Paez1, Guillermo Selman3, Diana R Hernandez1, Chad A Sundberg4, Jason Chieh Sheng Tey4, Yan-Ting Shiu4, Alfred K Cheung4,5,6, Michael Allon7, Omaida C Velazquez1, Loay H Salman3, Roberto I Vazquez-Padron8.   

Abstract

The frequency of primary failure in arteriovenous fistulas (AVFs) remains unacceptably high. This lack of improvement is due in part to a poor understanding of the pathobiology underlying AVF nonmaturation. This observational study quantified the progression of three vascular features, medial fibrosis, intimal hyperplasia (IH), and collagen fiber organization, during early AVF remodeling and evaluated the associations thereof with AVF nonmaturation. We obtained venous samples from patients undergoing two-stage upper-arm AVF surgeries at a single center, including intraoperative veins at the first-stage access creation surgery and AVFs at the second-stage transposition procedure. Paired venous samples from both stages were used to evaluate change in these vascular features after anastomosis. Anatomic nonmaturation (AVF diameter never ≥6 mm) occurred in 39 of 161 (24%) patients. Neither preexisting fibrosis nor IH predicted AVF outcomes. Postoperative medial fibrosis associated with nonmaturation (odds ratio [OR], 1.55; 95% confidence interval [95% CI], 1.05 to 2.30; P=0.03, per 10% absolute increase in fibrosis), whereas postoperative IH only associated with failure in those individuals with medial fibrosis over the population's median value (OR, 2.63; 95% CI, 1.07 to 6.46; P=0.04, per increase of 1 in the intima/media ratio). Analysis of postoperative medial collagen organization revealed that circumferential alignment of fibers around the lumen associated with AVF nonmaturation (OR, 1.38; 95% CI, 1.03 to 1.84; P=0.03, per 10° increase in angle). This study demonstrates that excessive fibrotic remodeling of the vein after AVF creation is an important risk factor for nonmaturation and that high medial fibrosis determines the stenotic potential of IH.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  arteriovenous fistula; fibrosis; vascular access

Mesh:

Substances:

Year:  2018        PMID: 29295872      PMCID: PMC5827597          DOI: 10.1681/ASN.2017050559

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  19 in total

1.  Association between Preoperative Vascular Function and Postoperative Arteriovenous Fistula Development.

Authors:  Michael Allon; Tom Greene; Laura M Dember; Joseph A Vita; Alfred K Cheung; Naomi M Hamburg; Peter B Imrey; James S Kaufman; Michelle L Robbin; Yan-Ting Shiu; Christi M Terry; Heidi R Umphrey; Harold I Feldman
Journal:  J Am Soc Nephrol       Date:  2016-05-09       Impact factor: 10.121

2.  Arteriovenous Fistula Development in the First 6 Weeks after Creation.

Authors:  Michelle L Robbin; Tom Greene; Alfred K Cheung; Michael Allon; Scott A Berceli; James S Kaufman; Matthew Allen; Peter B Imrey; Milena K Radeva; Yan-Ting Shiu; Heidi R Umphrey; Carlton J Young
Journal:  Radiology       Date:  2015-12-22       Impact factor: 11.105

3.  Medial fibrosis, vascular calcification, intimal hyperplasia, and arteriovenous fistula maturation.

Authors:  Michael Allon; Silvio Litovsky; Carlton J Young; Mark H Deierhoi; Jeremy Goodman; Michael Hanaway; Mark E Lockhart; Michelle L Robbin
Journal:  Am J Kidney Dis       Date:  2011-06-30       Impact factor: 8.860

4.  Pre-existing histopathological changes in the cephalic vein of renal failure patients before arterio-venous fistula (AVF) construction.

Authors:  Mahmoud A Wali; Refaat A Eid; Madhu Dewan; Mohammad A Al-Homrany
Journal:  Ann Thorac Cardiovasc Surg       Date:  2006-10       Impact factor: 1.520

5.  Preoperative Vascular Medial Fibrosis and Arteriovenous Fistula Development.

Authors:  Yan-Ting Shiu; Silvio H Litovsky; Alfred K Cheung; Daniel B Pike; Jason Chieh Sheng Tey; Yingying Zhang; Carlton J Young; Michelle Robbin; Kenneth Hoyt; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-30       Impact factor: 8.237

6.  Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosis.

Authors:  Simona Simone; Antonia Loverre; Marica Cariello; Chiara Divella; Giuseppe Castellano; Loreto Gesualdo; Giovanni Pertosa; Giuseppe Grandaliano
Journal:  J Nephrol       Date:  2014-02-27       Impact factor: 3.902

7.  Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients.

Authors:  Gunnar H Heine; Christof Ulrich; Urban Sester; Martina Sester; Hans Köhler; Matthias Girndt
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

8.  Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomes.

Authors:  Michael Allon; Michelle L Robbin; Carlton J Young; Mark H Deierhoi; Jeremy Goodman; Michael Hanaway; Mark E Lockhart; Silvio Litovsky
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

9.  Involvement of MMPs in the outward remodeling of collateral mesenteric arteries.

Authors:  Tara L Haas; Jennifer L Doyle; Matthew R Distasi; Laura E Norton; Kevin M Sheridan; Joseph L Unthank
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-20       Impact factor: 4.733

Review 10.  Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications.

Authors:  Adam Harvey; Augusto C Montezano; Rheure Alves Lopes; Francisco Rios; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2016-03-03       Impact factor: 5.223

View more
  13 in total

Review 1.  Arteriovenous conduits for hemodialysis: how to better modulate the pathophysiological vascular response to optimize vascular access durability.

Authors:  Yan-Ting Shiu; Joris I Rotmans; Wouter Jan Geelhoed; Daniel B Pike; Timmy Lee
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-20

Review 2.  Intimal Hyperplasia and Arteriovenous Fistula Failure: Looking Beyond Size Differences.

Authors:  Roberto I Vazquez-Padron; Juan C Duque; Marwan Tabbara; Loay H Salman; Laisel Martinez
Journal:  Kidney360       Date:  2021-08

3.  Systemic Profile of Cytokines in Arteriovenous Fistula Patients and Their Associations with Maturation Failure.

Authors:  Laisel Martinez; Mikael Perla; Marwan Tabbara; Juan C Duque; Miguel G Rojas; Nieves Santos Falcon; Simone Pereira-Simon; Loay H Salman; Roberto I Vazquez-Padron
Journal:  Kidney360       Date:  2022-01-13

4.  Atorvastatin Reduces In Vivo Fibrin Deposition and Macrophage Accumulation, and Improves Primary Patency Duration and Maturation of Murine Arteriovenous Fistula.

Authors:  Jie Cui; Chase W Kessinger; Harkamal S Jhajj; Madeleine S Grau; Sanjay Misra; Peter Libby; Jason R McCarthy; Farouc A Jaffer
Journal:  J Am Soc Nephrol       Date:  2020-03-09       Impact factor: 10.121

5.  1α,25-Dihydroxyvitamin D3 Encapsulated in Nanoparticles Prevents Venous Neointimal Hyperplasia and Stenosis in Porcine Arteriovenous Fistulas.

Authors:  Avishek K Singh; Chuanqi Cai; Sreenivasulu Kilari; Chenglei Zhao; Michael L Simeon; Edwin Takahashi; Elazer R Edelman; Hyunjoon Joon Kong; Thanila Macedo; Ravinder J Singh; Matthew W Urban; Rajiv Kumar; Sanjay Misra
Journal:  J Am Soc Nephrol       Date:  2021-02-24       Impact factor: 10.121

6.  The anatomical sources of neointimal cells in the arteriovenous fistula.

Authors:  Roberto I Vazquez-Padron; Laisel Martinez; Juan C Duque; Loay H Salman; Marwan Tabbara
Journal:  J Vasc Access       Date:  2021-05-07       Impact factor: 2.283

Review 7.  Mineralocorticoid receptor: A hidden culprit for hemodialysis vascular access dysfunction.

Authors:  Bohan Chen; Pei Wang; Andrew Brem; Lance Dworkin; Zhangsuo Liu; Rujun Gong
Journal:  EBioMedicine       Date:  2018-12-05       Impact factor: 8.143

8.  Periadventitial Delivery of Simvastatin-Loaded Microparticles Attenuate Venous Neointimal Hyperplasia Associated With Arteriovenous Fistula.

Authors:  Chenglei Zhao; Sean T Zuckerman; Chuanqi Cai; Sreenivasulu Kilari; Avishek Singh; Michael Simeon; Horst A von Recum; Julius N Korley; Sanjay Misra
Journal:  J Am Heart Assoc       Date:  2020-12-05       Impact factor: 5.501

9.  Inhibition of Lysyl Oxidase with β-aminopropionitrile Improves Venous Adaptation after Arteriovenous Fistula Creation.

Authors:  Diana R Hernandez; Brandon Applewhite; Laisel Martinez; Tyler Laurito; Marwan Tabbara; Miguel G Rojas; Yuntao Wei; Guillermo Selman; Marina Knysheva; Omaida C Velazquez; Loay H Salman; Fotios M Andreopoulos; Yan-Ting Shiu; Roberto I Vazquez-Padron
Journal:  Kidney360       Date:  2021-02-25

10.  Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula.

Authors:  Te-I Chang; Cheng-Hsien Chen; Po-Hsun Huang; Chung-Te Liu; Hui-Ling Hsieh; Chun-You Chen; Shih-Chang Hsu; Ho-Shun Cheng; Wen-Cheng Huang; Yuh-Mou Sue; Yung-Ho Hsu; Feng-Yen Lin; Chun-Ming Shih; Shing-Jong Lin
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.